MLMiao Liu

Miao Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Miao Liu has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nondisruptive 3D profiling of combinations of epigenetic marks in single cells

    by Yanbo Chen, Jonathan S. D. Radda, Myles H. Alderman, Shengyan Jin, Yubao Cheng, Yuan Zhang, Miao Liu, Andrew Z. Xiao, Siyuan Wang

    Advances in single-cell sequencing and spatial omics technologies have enhanced our understanding of diverse cellular identities, compositions, architectures and functions. However, the single-cell three-dimensional (3D) organization of the epigenome is still not well understood, due to an absence of spatial single-cell methods that allow high-resolution, locus-specific detection of combinations of epigenetic marks while maintaining 3D genome organization. Here we develop epigenetic proximity hybridization reaction (Epi-PHR), a nondisruptive image-based single-cell spatial epigenetic profiling technology. Epi-PHR detects combinations of epigenetic marks in situ at hundreds of gene targets within single cells while preserving 3D genome organization. Phased Epi-PHR combined with chromatin tracing reveals unexpected associations between epigenetic mark enrichment and chromatin folding of an imprinted gene cluster at the single-chromatin-copy level for the distinct alleles from different parental origins. We expect Epi-PHR will be broadly applicable in research requiring single-cell spatial epigenetic information, advancing our understanding of the combinatorial epigenetic code and its relationship with chromatin organization.

  • Open Access

    The dark transcriptome mouse organogenesis cell atlas

    by Miao Liu, Dingyao Zhang, Keyi Li, Yuval Kluger, Jun Lu, Mark B. Gerstein, Haikuo Li, Rong Fan

    Single-cell atlases have transformed our understanding of mammalian tissue biology, yet the diverse noncoding “dark transcriptome” remains largely uncharted. Here, we present the Dark Transcriptome Mouse Organogenesis Cell Atlas (DT-MOCA), comprising 276,455 cells across embryonic days 11 to 18 and jointly capturing protein-coding transcripts and five major classes of noncoding RNAs through single-nucleus total RNA sequencing, establishing the first comprehensive catalog of noncoding RNAs across major cell types and developmental lineages. We found that long noncoding RNA and microRNA profiles distinguished major cell types and developmental lineages with resolution comparable to messenger RNA, whereas transfer RNA, small nuclear RNA, and small nucleolar RNA programs were less cell type-discriminative and more broadly shared. We further resolve noncoding RNA expression patterns as lineage-specific, temporally modulated, or coordinately regulated by cell identity and developmental stage. We observed that temporally regulated long noncoding RNAs were evolutionarily younger than those associated with cell identity. We further generate a catalog of the change of noncoding RNAs cross all 11 major developmental trajectories. It revealed lineage-specific coordination between transfer RNA supply and codon demand during musculoskeletal organogenesis as well as dynamic microRNA and small nucleolar RNA programs during the central nervous system development. We observed microRNAs converge on regulators of proliferation and gliogenesis and shared induction of Snord116 defining a developmental window relevant to Prader–Willi syndrome. Together, this atlas provides a comprehensive catalog of the developmental dark transcriptome and reveals how noncoding RNA programs are organized across cell identity, developmental time, and lineage progression.

  • Open Access

    Differential analysis of image-based chromatin tracing data with Dory

    by Zhaoxia Ma, Miao Liu, Shengyuan Wang, Siyuan Wang, Chongzhi Zang

  • A 3D genome atlas of human tonsil and the role of loop extrusion in B cell somatic hypermutation

    by Yubao Cheng, Jianshu Wang, Yuan Zhang, Anurupa Devi Yadavalli, Miao Liu, Shengyan Jin, Grace Buddle, Ann Haberman, David G. Schatz, Siyuan Wang

    B cell maturation within the germinal center tissue microenvironment involves immunoglobulin gene diversification by somatic hypermutation (SHM). How three-dimensional (3D) genome architecture influences SHM is not fully understood. We leveraged sequencing-based and image-based 3D genomics and transcriptomics to map single-cell 3D genome organization and gene expression across cell types and states in human tonsils and in B cell lymphoma cell lines. These analyses revealed trajectories of compartment, looping, and nuclear position changes during the B cell immune response and activation of SHM. Targeted protein degradation of cohesin component RAD21 revealed its contribution to enabling SHM. Our results provide a single-cell 3D genome atlas of human tonsil cells and outline the links between the chromatin loop extrusion machinery and SHM.


  • 3D multi-omics tumour atlases: from technology to biology and clinical translation

    by Miao Liu, Jorge Villazon, André Forjaz, Xiaolong Tian, Rong Fan, Siyuan Wang, Lingyan Shi, Denis Wirtz, Ashley L. Kiemen

    Human tumours consist of highly heterogeneous and interacting cell types organized within a complex 3D space, forming a dynamic ecosystem that evolves through the development of pre-malignant lesions, tumour initiation, progression, invasion and metastasis. Understanding the operational principles of tumour evolution at a holistic 3D level is critical for improving the ability to intercept and treat cancer early. Emerging technologies in spatial multi-omics and the generation of 3D tumour atlases are beginning to address this critical need. These efforts aim to capture the intricate interactions within precancerous lesions, tumours and their surrounding ecosystems over space and time. In this Review, we highlight emerging tools developed within and beyond the tumour atlas community and explore their potential in constructing comprehensive 3D tumour atlases. Such atlases have the potential to reveal novel biomarkers for risk stratification, early detection, preventive intervention, and transformative diagnostic and treatment strategies. Furthermore, a 3D tumour atlas can generate new insights into the molecular and cellular mechanisms driving human tumour evolution, paving the way for future research and innovation in cancer biology.


  • Top Cited Papers
    Open Access

    Large-scale, spatially resolved panoramic CRISPR screening in native tissue environments using Perturb-DBiT

    by Alev Baysoy, Xiaolong Tian, Paul Renauer, Feifei Zhang, Zhiliang Bai, Hao Shi, Mingyu Yang, Dingyao Zhang, Miao Liu, Haikuo Li, et al.

    Spatially resolved CRISPR screening in vivo has been limited to small perturbation panels and subsets of protein-coding RNAs. We present Perturb-DBiT, a method for co-sequencing of spatial total RNA whole transcriptomes and single guide RNAs (sgRNAs) on the same tissue section in situ. In a human cancer metastatic colonization model, we applied large (80,000+) sgRNA panels across tumor colonies in multiple consecutive tissue sections alongside their corresponding total RNA transcriptomes. We linked perturbations affecting long noncoding RNA covariation, microRNA–mRNA interactions and distinct amino acid-specific tRNA alterations to tumor migration and growth. By integrating transcriptional pseudotime trajectories, we further observed the impact of perturbations on clonal dynamics and cooperation. In an immune-competent syngeneic mouse model, investigation of the tumor immune microenvironment indicated distinct, synergistic effects on immune infiltration and suppression. Perturb-DBiT provides a spatially resolved comprehensive view of perturbation responses in complex tissues, including small and large RNA regulation, tumor proliferation, migration, metastasis and immune interactions.


  • Open Access

    Tracing the evolution of single-cell 3D genomes in Kras-driven cancers

    by Miao Liu, Shengyan Jin, Sherry S. Agabiti, Tyler B. Jensen, Tianqi Yang, Jonathan S. D. Radda, Christian F. Ruiz, Gabriel Baldissera, Moein Rajaei, Fang-Yong Li, et al.

    Although three-dimensional (3D) genome structures are altered in cancer, it remains unclear how these changes evolve and diversify during cancer progression. Leveraging genome-wide chromatin tracing to visualize 3D genome folding directly in tissues, we generated 3D genome cancer atlases of oncogenic Kras-driven mouse lung adenocarcinoma (LUAD) and pancreatic ductal adenocarcinoma. Here we define nonmonotonic, stage-specific alterations in 3D genome compaction, heterogeneity and compartmentalization as cancers progress from normal to preinvasive and ultimately to invasive tumors, discovering a potential structural bottleneck in early tumor progression. Remarkably, 3D genome architectures distinguish morphologic cancer states in single cells, despite considerable cell-to-cell heterogeneity. Analyses of genome compartmentalization changes not only showed that compartment-associated genes are more homogeneously regulated but also elucidated prognostic and dependency genes in LUAD, as well as an unexpected role for Rnf2 in 3D genome regulation. Our results highlight the power of single-cell 3D genome mapping to identify diagnostic, prognostic and therapeutic biomarkers in cancer.